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AsthmaAbstract The study was carried out to investigate the effects of inhaled Mg alone and associated
with F in the treatment of bronchial hyperresponsiveness. 43 male Wistar rats were randomly
divided into four groups and exposed to inhaled NaCl 0.9%, MeCh, MgSO4 and MgF2. Pulmonary
changes were assessed by means of functional tests and quantitative histological examination of
lungs and trachea. Results revealed that delivery of inhaled Mg associated with F led to a signiﬁcant
decrease of total lung resistance better than inhaled Mg alone (p< 0.05). Histological examinations
illustrated that inhaled Mg associated with F markedly suppressed muscular hypertrophy
(p= 0.034) and bronchoconstriction (p= 0.006) in MeCh treated rats better than inhaled Mg
alone. No histological changes were found in the trachea. This study showed that inhaled Mg asso-
ciated with F attenuated the main principle of the central components of changes in MeCh pro-
voked experimental asthma better than inhaled Mg alone, potentially providing a new
therapeutic approach against asthma.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.Introduction
Asthma is a serious global health problem, throughout the
world affecting over 300 million people of all ages. Asthma
is a chronic disease characterized by a variety of features,
including increased airway responsiveness, airway inﬂamma-
tion and reversible airway obstruction. According to the Glo-
bal Initiative for Asthma (GINA), the deﬁnition of asthma is
based on an operational description. In these terms:
536 F. Gandia et al.‘‘Asthma is a chronic inﬂammatory disorder of the airways in
which many cells and cellular elements play a role. The
chronic inﬂammation causes an associated increase in airway
hyperresponsiveness that leads to recurrent episodes of
wheezing, breathlessness, chest tightness, and coughing, par-
ticularly at night or in the early morning. These episodes are
usually associated with widespread but variable airﬂow
obstruction that is often reversible either spontaneously or
with treatment’’ [1].
Several studies [2–4], had conﬁrmed the bronchodilating ef-
fects of intravenous Mg, but its effects through inhalation are
controversial [5–8]. Mg has been reported in many researches
to inhibit theCa2+ inﬂuxby blocking the voltage-dependent cal-
cium channels, modulate the vaso-activity by affecting the inﬂux
of extracellular Ca2+ through dihydropyridine-sensitive, volt-
age-dependent channels, which accounts formuch of its relaxing
action on airway [9,10]. In vitro studies showed that the magne-
sium ion (Mg2+) modulates smooth muscle contractility and
mediates release by antagonism of the action of calcium [11,12].
The bronchodilator effect of ﬂuoride is poorly documented.
Cushing et al., found that NaF relaxed arteries by releasing an
endothelium derived relaxing factor and one or more prosta-
noids [13]. Zaho et al. proved that NaF induced bronchial relax-
ation on precontracted bovine bronchi in vitro and rats in vivo.
In fact, ﬂuoride is an inhibitor of enolase, an enzyme of the
glycolysis pathway leading to phosphoenolpyruvate [14,15].
As compared with physiological studies, there are a few
detailed histological studies on the respiratory system, especially
in the lung, of humans or rats exposed by inhalation to Mg
alone or when associated with ﬂuoride.
The purposes of this study were to investigate the changes
in the pulmonary function as well as in the histology in the
lung of Wistar rats which were challenged with MeCh and then
exposed by inhalation to Mg alone and when associated with
ﬂuoride.
Materials and methods
The study protocol used in the present study was approved by
the Animal Ethics Committee of the Faculty of Medicine of
Sousse, Tunisia, where the experiments were carried out.
Animals
Forty-three male Wistar adult rats (180 g ± 30 g) were in-
cluded in the study. Rats were randomly assigned to four
groups: Controls (N= 14), MeCh alone (N= 10), MgSO4
(N= 9) and MgF2 (N= 10).
Total lung resistances measurement
Rats were anesthetized intraperitoneally with ketamine
(150 mg/kg). After dissecting the neck, a tracheal cannula
was inserted into a mid-line incision of the trachea. A catheter
was inserted into the esophagus and connected to a pressure
transducer to measure the intra-esophageal pressure. A small
pneumotachograph (PTG, 8431B, Hans Rudolph, Kansas,
USA) was connected to tracheal cannula. The period of mea-
surement of the ﬂow rate with the PTG was set at 10 s to avoid
a change in ventilation due to the PTG dead volume. The PTGwas connected to a differential pressure transducer. Both pres-
sure and ﬂow transducers were assembled together with con-
necting valves to ease the calibration. Calibration in volume
was done daily with a 10 ml syringe. Total lung resistance
(R) was calculated by using a ﬁrst order mechanical model
of the lung. Aerosols were made through a DeVilbiss nebulizer
(Ref 123016 Marquette Medical products, Englewood co.
USA) connected to a compressor (ﬂow rate 100 ml/s). Aerosols
were delivered at a ﬂow rate of 0.1 ml/s in a rigid plastic cham-
ber placed over the rat body. Bronchoconstriction was induced
by gradually increasing concentrations of MeCh: 0.5 mg/L,
1 mg/L, 2.12 mg/L, 4.25 mg/L, 8.5 mg/L, 17 mg/L, 34 mg/L
and 68 mg/L. MeCh solutions were aerosolized within the
chamber for 1 min with 3 min intervals between doses.
MgSO4 and MgF2 inhaled aerosols were delivered for one
minute after each dose of MeCh from the fourth dose of
MeCh. The total lung resistances (R) were measured before
the challenge, after an aerosol of isotonic saline and 2 min after
each dose of MeCh.
Histology
At the end of the protocols, the rats were sacriﬁced; the lungs
and trachea were removed. Longitudinal sections were taken
from the left and right lung and trachea sections were cut
transversely. The lungs and trachea sections were processed
by routine histological procedures for parafﬁn embedding.
Five-micrometer thick histological sections were stained with
hematoxylin and eosin, and examined by light microscopy.
Histological modiﬁcations of the lungs and trachea were
assessed by means of a quantitative histological score. The
degrees of inﬂammation, mucus, muscular hypertrophy,
bronchial dilatation and emphysema were scored from 0
(absent) to 3 (intense) by two pathologists who examined the
slides at the same time under a double-observation microscope.
The histological slides were coded and the two investigators
were unaware of the origin of the material during scoring.
Chemicals
MgSO4, acetic acid and ketamine were purchased from Sigma
(St. Louis, MI, USA) and MeCh from Allerbio (Lavarenne,
France). MgF2 was dissolved in acetic acid to improve the
solubility.
Magnesium ﬂuoride, random crystals, 99.99+%, optical
grade: purchased from (Sigma, Aldrich).
Solutions synthesis
MgF2 was dissolved in acetic acid to improve the solubility.
MgF2 solutionwas prepared and stored in polyethylene or poly-
propylene bottles in order to prevent attack on glass surfaces.
Data analysis
All data are reported as mean ± SEM. Mean values of R be-
tween control and other groups were compared using the
Mann–Whitney’s U test. Comparison of rat’s resistance (R)
values among the same group of rats at different concentra-
tions of MeCh was made using the paired Student’s t-test.
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were analyzed with a two-way ANOVA.
The histological scores were analyzed by the Kruskal–Wal-
lis test and multiple comparison procedures. When comparing
controls with the two groups (MgSO4 and MgF2), Student’s
t-test and the Mann–Whitney’s test were employed. A p value
<0.05 was considered signiﬁcant.
Results
Effects of inhaled Mg alone and Mg associated with F on R
values
Basal resistances were not different for all groups. R value in
the control group receiving MeCh increased signiﬁcantly withTable 1 Effect of inhaled magnesium on lung histology score.
Groups N rat Inﬂammation Mucus
Control 1 3 0
2 0 0
3 1 1
4 0 0
5 0 1
6 1 0
7 0 0
8 0 0
9 2 0
10 0 0
11 0 0
12 1 0
13 0 1
14 1 0
MeCh 1 0 1
2 1 1
3 1 1
4 2 0
5 2 1
6 2 0
7 1 1
8 1 0
9 2 1
10 2 1
MgF2 1 1 0
2 0 0
3 2 0
4 1 1
5 1 0
6 0 0
7 2 0
8 0 0
9 1 0
10 0 0
MgSO4 1 1 1
2 0 0
3 2 0
4 1 1
5 3 0
6 1 0
7 2 0
8 0 1
9 2 0
Kruskal–Wallis (valeur de p) 0.07 0.025
P value for comparison of the four groups (Kruskal–Wallis test).the cumulative doses of MeCh. Compared to the base value of
R, at the start of the challenge, the increase was signiﬁcant at
the fourth dose = 4.25 mg/L (p< 0.05).
Histological ﬁndings
Table 1 shows the results of the histological scoring of the lung
(inﬂammation, mucus, muscular hypertrophy, bronchial dila-
tation and emphysema). Histological examination of the trans-
versal sections of the trachea of the different groups does not
show signiﬁcant histological abnormalities or changes.
The comparison of the lungs histological scoring of the four
groups by the Kruskal–Wallis test, mucus, muscular hypertro-
phy and bronchial dilatation exhibited signiﬁcant differences
among groups (p= 0.0259, p= 0.0338 and p= 0.001,Muscular hypertrophy Bronchial lumen dilation Emphysema
0 1 0
1 1 1
0 1 1
0 1 0
1 1 0
1 1 0
0 1 0
1 2 0
0 1 0
0 2 0
2 1 0
0 2 0
0 0 0
1 1 0
0 0 0
1 0 0
0 0 0
1 0 0
1 0 0
2 0 0
2 1 0
2 0 0
1 0 0
1 0 0
0 3 0
0 0 0
1 3 0
0 2 0
0 2 0
1 1 0
1 2 0
0 2 0
0 2 1
0 3 0
1 1 0
1 2 0
1 2 0
0 0 0
1 1 0
0 1 0
2 0 0
1 0 0
1 2 0
0.033 0.0001 0.447
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MgF2 group by the Mann–Whitney’s test, the MgF2 group
presented a signiﬁcant difference in bronchial dilatation
(p= 0.006) and muscular hypertrophy (p= 0.034) (Table 1).
Discussion
In this study we investigated the effects of inhaled magnesium
alone and when associated with ﬂuoride on rats pre-contracted
by cumulative doses ofMeCh.We found that inhaledmagnesium
(0.5 M) reversed bronchospasma but the association of magne-
sium and ﬂuoride (MgF2) ([Mg] = 0.08 mM, [F] = 0.084 mM)
had a better bronchodilator effect (decrease of total lung
resistances, p< 0.05, bronchial lumen dilatation, p= 0.006
and muscular hypertrophy, p= 0.034) (Fig. 1) (Table 1).
MeCh was used to challenge the rat before any administra-
tion. In fact, it was reported as a synthetic muscarinic agonist
more stable than acetylcholine and better tolerated than hista-
mine or carbachol [16]. In addition, MeCh rarely induced
cough. Our experimental results demonstrated that MeCh in-
duced severe bronchoconstriction in experimental rats. In fact,
the comparison of the control and MeCh groups using the
Mann–Whitney’s U-test revealed signiﬁcant differences in the
total lung resistances (R) ( p< 0.05) that start at the fourth
dose of MeCh (4.25 mg/L). Moreover, the comparison of the
histological score of the same groups by the Mann–Whitney’s
test, revealed a signiﬁcant difference in the mucus presence
(p= 0.019), muscular hypertrophy ( p= 0.049) and in the
bronchial lumen dilatation ( p= 0.000132) (Table 1). Histo-
logical observation demonstrated a narrowed and scalloped
lumen bronchiole surrounded by a thick layer of muscle
(bronchoconstriction) with presence of mucus in the bronchial
lumen (Fig. 3).
While the bronchodilating effect of magnesium adminis-
tered intravenously has been conﬁrmed by several studies [2–
4], its effect through inhalation is controversial and poorly
documented. Recent and previous studies concluded that treat-
ment with nebulised MgSO4 alone was difﬁcult to draw due to
lack of studies in this area [17–19]. Rolla following a study of 9Figure 1 Effect of inhaled MeCh, MgSO4 and MgF2 on R
values. *p< 0.05, signiﬁcant increase in bronchial resistance that
starts at the fourth dose of MeCh (4.25 mg/L). **p< 0.05, Mann–
Whitney U test. The comparison between MgF2 and MgSO4
groups using the Mann–Whitney’s U-test revealed signiﬁcant
differences in airway resistance (P< 0.05) that starts at the fourth
dose of MeCh (4.25 mg/L).cases showed that asthma administered inhaled MgSO4 led to
a reduction in bronchial reactivity to histamine [20]. Indeed,
Bessmertny et al. showed that MgSO4 can directly inhibit his-
tamine release from mast cells and stimulate the production of
NO and prostacyclin synthesis [21]. However, Hill has shown
that inhaled MgSO4 may increase bronchial responsiveness
in these patients [22]. In another trial, carried out by Tiffany
et al., a beneﬁcial effect of magnesium was not, however,
found [8]. We have therefore undertaken this study to try to
clarify this controversy. Magnesium was administered as
MgSO4 at 0.5 M. At high concentrations, this cation produces
signiﬁcant toxicity. Infact, hypermagnesemia induce paralysis
of skeletal muscles, reduce lung capacity and sometimes even
causes coma and death. The results of this study were in agree-
ment with previous studies of Rolla and colleagues [20] that
conﬁrmed the bronchorelaxant effect of inhaled MgSO4. In-
haled MgSO4 by hyperactive asthmatic patients during
(MCT), had bronchodilating effects. In our study, inhaled
MgSO4 decrease R values (p< 0.05), inﬂammation
(p= 0.01) and bronchial dilatation (p= 0008). Histological
observation illustrated a bronchiole with a little scalloped lu-
men (moderate bronchodilation), low abundance of mucus
and a thin muscle layer (Figs. 1 and 3). Magnesium’s pharma-
cological action is based upon its ability to inhibit the release
of calcium from vesicles in the sarcoplasmic reticulum, result-
ing in bronchial smooth muscle relaxation [9,10].
The histological results were consistent with the physiologi-
cal data; the rats treated with inhaled Mg associated with
Fluoride (MgF2) had better improvement in R values, broncho-
constriction and muscular hypertrophy than rats treated with
inhaled Mg alone. Our histological results revealed that there
was a bronchodilation with thinning of the muscles and no mu-
cus. However, there was persistent peribronchial inﬂammation
(lymphoplasmocytis inﬂammation) in MeCh, MgSO4 and
MgF2 groups (p> 0.05) (Fig. 3). Further, transversal sections
of trachea of the different groups did not show signiﬁcant histo-
logical changes (regular diameter, no mucus, and absence of
thickening of tracheal muscle); this result can be explained by
the low abundance of smooth muscle in the trachea (Fig. 2).Figure 2 Section of trachea rat after inhaled magnesium
exposure. Transversal sections of the trachea of the different
groups (control, MeCh, MgSO4 and MgF2) did not show
signiﬁcant histological changes (regular diameter, no mucus and
absence of thickening of tracheal muscle). Hematoxylin–eosin
staining. Original magniﬁcation was 40·.
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Figure 3 Histological changes in rat lung following inhaled magnesium exposure. Sections of lung rats (control, A), (MeCh, B), (MgSO4,
C) and (MgF2, D). BL, bronchial lumen, M, mucus. Arrowheads indicate peribronchial inﬂammation (B–D). Hematoxylin–eosin staining.
(Original magniﬁcation: A, C and D= 200·; B = 100·).
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Fluoride had been reported to stimulate adenylate cyclase
activity on smooth muscles and induced NO synthesis which
would relax bronchi [11,23]. The better known bronchodilator
mechanism of ﬂuoride is induced by inhibition of the glycolytic
enzyme, enolase, which converts 2-phospho-glycerate to phos-
phoenolpyruvate according to [15]. The inhibition of glycolysis
induced by ﬂuoride is illustrated by the sharp decrease in lac-
tate production in its presence. Inhibition of this enzyme
would be expected to reduce glycolytic ATP production and
impair smooth muscle contraction [14].
Then, the association of magnesium and ﬂuoride makes a
powerful bronchodilator that acts in micromolar dose ranges
compared to MgSO4 (0.5 M) alone. In the present study, in-
haled doses of MgSO4, NaF and MgF2 were very low and
far from the toxic doses of magnesium and ﬂuoride [24,25].
It is difﬁcult to assess the dose of MgF2 needed for the treat-
ment of asthma as this study seems to be the ﬁrst to demon-
strate its bronchodilating effect in vivo. The duration of the
bronchorelaxant effect of MgSO4 and MgF2 is not known
and needs further study.
Conclusion
Magnesium associated with ﬂuoride and administered as
inhaled MgF2 is a double combination able to induce asigniﬁcant and constant bronchodilating effect through two
different pathways. Their effects were additive.
In addition, the association of Mg with F provides immedi-
ate bronchodilation when inhaled in a state of bronchocon-
striction. This supports the use of this association for both
relief and prevention of asthma symptoms. However, the opti-
mum dose–response relationship needs to be addressed in fu-
ture studies. In addition, further research in this area should
be encouraged to determine the potential mechanism in which
inhaled MgF2 enhanced bronchospasma.Conﬂict of interest
The authors declare that there is no conﬂict of interest.
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